Skip to main content
Clinical Trials/NCT00773500
NCT00773500CompletedNot Applicable

Impact of Vendor Systems on Ambulatory Medication Safety

Weill Medical College of Cornell University2 sites in 1 country20 target enrollmentStarted: September 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
2
Primary Endpoint
prescribing error

Study Overview

Brief Summary

Our objective is to determine the effects of electronic prescribing on medication safety including medication errors, near misses and preventable adverse drug events in the ambulatory setting. Study design will be a longitudinal evaluation of errors early after implementation and after sustained use.

Detailed Description

We will compare the effects of different vendor-based electronic prescribing systems on ambulatory medication safety in various settings, including rural and underserved areas and determine the effects of electronic prescribing systems on ambulatory medication safety over time.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • >=0.75 FTE providers

Exclusion Criteria

  • <0.75 FTE providers

Outcomes

Primary Outcomes

prescribing error

Time Frame: 1 year

Secondary Outcomes

  • near misses(1 year)
  • preventable adverse drug events(1 year)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Impact of Vendor Systems on Ambulatory... | Clinical Trial